Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Lin

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Annals of Surgery|April 4, 2012
Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomyEdward I Chang, Anne Warren Peled, Robert D Foster, et al.
BMC Medical Education|July 24, 2019
The impact of a fellow-driven debriefing program after pediatric cardiac arrestsJennifer Gillen, Monica L Koncicki, Rebecca F Hough, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Annals of Surgery|April 4, 2012
Evaluating the feasibility of extended partial mastectomy and immediate reduction mammoplasty reconstruction as an alternative to mastectomyEdward I Chang, Anne Warren Peled, Robert D Foster, et al.
BMC Medical Education|July 24, 2019
The impact of a fellow-driven debriefing program after pediatric cardiac arrestsJennifer Gillen, Monica L Koncicki, Rebecca F Hough, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Pageof 4